Tianhao Zou

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Targeting taurine metabolism via PROTAC-mediated SLC6A6 degradation potentiates photodynamic therapy and reverses immunosuppression in cholangiocarcinoma.

Targeting taurine metabolism via PROTAC-mediated SLC6A6 degradation potentiates photodynamic therapy and reverses immunosuppression in cholangiocarcinoma.

Journal: Journal of nanobiotechnology

Published: March 29, 2026

Intrahepatic Splenosis Mimicking Hepatocellular Carcinoma: A Case Series of Eleven Patients.

Intrahepatic Splenosis Mimicking Hepatocellular Carcinoma: A Case Series of Eleven Patients.

Journal: Current medical imaging

Published: October 11, 2025

HDAC5 deficiency induces intrinsic resistance to KRAS inhibition by disrupting c-Myc acetylation-ubiquitination homeostasis.

HDAC5 deficiency induces intrinsic resistance to KRAS inhibition by disrupting c-Myc acetylation-ubiquitination homeostasis.

Journal: The Journal of clinical investigation

Published: May 20, 2025

Adenosine metabolic clearance maintains liver homeostasis by licensing arginine methylation of RIPK1.

Adenosine metabolic clearance maintains liver homeostasis by licensing arginine methylation of RIPK1.

Journal: The Journal of experimental medicine

Published: March 20, 2025

Hexosamine biosynthesis dysfunction-induced LIFR N-glycosylation deficiency exacerbates steatotic liver ischemia/reperfusion injury.

Hexosamine biosynthesis dysfunction-induced LIFR N-glycosylation deficiency exacerbates steatotic liver ischemia/reperfusion injury.

Journal: Metabolism: clinical and experimental

Published: March 06, 2025

Lachnospiraceae-bacterium alleviates ischemia-reperfusion injury in steatotic donor liver by inhibiting ferroptosis via the Foxo3-Alox15 signaling pathway.

Lachnospiraceae-bacterium alleviates ischemia-reperfusion injury in steatotic donor liver by inhibiting ferroptosis via the Foxo3-Alox15 signaling pathway.

Journal: Gut microbes

Published: January 30, 2025

A glucose kinase-independent HK2 activity prevents TNF-induced cell death by phosphorylating RIPK1.

A glucose kinase-independent HK2 activity prevents TNF-induced cell death by phosphorylating RIPK1.

Journal: Nature communications

Published: January 20, 2025

HDAC5 depletion promotes hyper-acetylation of FOXA1 and potentiates HIF1α transcriptional activation in pancreatic cancer.

HDAC5 depletion promotes hyper-acetylation of FOXA1 and potentiates HIF1α transcriptional activation in pancreatic cancer.

Journal: Molecular cell

Published: April 25, 2024

ZBP1-mediated apoptosis and inflammation exacerbate steatotic liver ischemia/reperfusion injury.

ZBP1-mediated apoptosis and inflammation exacerbate steatotic liver ischemia/reperfusion injury.

Journal: The Journal of clinical investigation

Published: February 20, 2024

Necroptosis-Mediated Synergistic Photodynamic and Glutamine-Metabolic Therapy Enabled by a Biomimetic Targeting Nanosystem for Cholangiocarcinoma.

Necroptosis-Mediated Synergistic Photodynamic and Glutamine-Metabolic Therapy Enabled by a Biomimetic Targeting Nanosystem for Cholangiocarcinoma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 28, 2023

A NRF2 Regulated and the Immunosuppressive Microenvironment Reversed Nanoplatform for Cholangiocarcinoma Photodynamic-Gas Therapy.

A NRF2 Regulated and the Immunosuppressive Microenvironment Reversed Nanoplatform for Cholangiocarcinoma Photodynamic-Gas Therapy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: September 27, 2023

Cell therapy for neuropathic pain.

Cell therapy for neuropathic pain.

Journal: Frontiers in molecular neuroscience

Published: December 08, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026